Psychiatric Devices: Medtronic OCD Approval, Depression Trial Announced

The medical device industry took another step into the field of psychiatry Feb. 19 with FDA's humanitarian device exemption of Medtronic's Reclaim deep brain stimulator for treating patients with severe obsessive-compulsive disorder

More from Archive

More from Medtech Insight